Search
OptimizeRx Corp
OPRXAdd to Watchlist
6.190USD
+0.110+1.81%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
116.16MMarket Cap
16.76P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.81%
5 Days
+26.33%
1 Month
+17.23%
6 Months
-50.16%
Year to Date
-49.51%
1 Year
-52.82%
Key Figures
6.140Open
6.500High
519.64KVolume
16.76P/E TTM
5.48P/E Dynamic
--Dividend TTM
2.77%Turnover Ratio
6.080Prev. Close
6.040Low
2.72MTurnover
LossP/E Static
0.90P/B
0.00%Div Yield TTM
4.08%ROA
22.25052wk High
1.24Volume Ratio
-20.11MNet Profit
18.77MShares
0.3693EPS TTM
1.14Beta
5.56%ROE
4.57052wk Low
7.57%Amplitude
69.89%Gross Margin
116.16MMarket Cap
5.58Reward/Risk
4.09%Risk Rate
TradingKey Stock Score of OptimizeRx Corp
Currency: USD Updated: 2026-07-02Key Insights
OptimizeRx Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 93 out of 486 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.40.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OptimizeRx Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
OptimizeRx Corp Highlights
StrengthsRisks
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.00% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 16.76, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 15.47M shares, decreasing 25.02% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 1.14M shares of this stock.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
12.400
Target Price
+128.36%
Upside Space
OptimizeRx Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OptimizeRx Corp Info
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Ticker SymbolOPRX
CompanyOptimizeRx Corp
CEOSilvestro (Stephen L)
Websitehttps://www.optimizerx.com/
Related Instruments
-1.78%
-0.36%
-0.48%
+1.62%
-4.90%
+2.99%
+3.24%
-1.64%
+4.66%
+2.84%
+1.03%
-1.13%
-1.87%
+2.17%
-6.65%
+2.42%
+1.76%
-0.16%
-1.72%
+0.34%Popular Instruments
53030.200
+187.700 (+0.35%)
29550.300
+238.900 (+0.81%)
7505.300
+33.800 (+0.45%)
15060.000
+257.000 (+1.74%)
69449.000
+1301.000 (+1.91%)
6380.400
+27.600 (+0.43%)
68.953
+0.609 (+0.89%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4177.710
+55.800 (+1.35%)
FAQs
What is the current price of OptimizeRx Corp (OPRX)?
The current price of OptimizeRx Corp (OPRX) is 6.19.
What is the symbol of OptimizeRx Corp?
The ticker symbol of OptimizeRx Corp is OPRX.
What is the 52-week high of OptimizeRx Corp?
The 52-week high of OptimizeRx Corp is 22.25.
What is the 52-week low of OptimizeRx Corp?
The 52-week low of OptimizeRx Corp is 4.57.
What is the market capitalization of OptimizeRx Corp?
The market capitalization of OptimizeRx Corp is 116.16M.
Is OptimizeRx Corp (OPRX) currently rated as Buy, Hold, or Sell?
According to analysts, OptimizeRx Corp (OPRX) has an overall rating of Buy, with a price target of 12.40.
What is the Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX)?
The Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX) is 0.28.